A 48 years old female suffering from severe menorrhagia (DUB) underwent hysterectomy. She wishes to take hormone replacement therapy. Physical examination and breast are normal but X-ray shows osteoporosis. The treatment of choice is:
**Core Concept**
Menorrhagia in a premenopausal woman (DUB) often involves unopposed estrogen, which can stimulate the endometrium and exacerbate symptoms. However, in a post-hysterectomy patient, the primary concern is preventing estrogen dominance, which can worsen osteoporosis. The goal of hormone replacement therapy (HRT) in this scenario is to balance estrogen and progesterone levels to mitigate menopausal symptoms while protecting against osteoporosis.
**Why the Correct Answer is Right**
The patient's osteoporosis necessitates the use of a combination of estrogen and progesterone to prevent further bone loss. Since she underwent a hysterectomy, the progesterone component is necessary to protect against endometrial cancer and prevent unopposed estrogen effects. This dual approach will help alleviate menopausal symptoms, such as hot flashes and vaginal dryness, while also addressing the patient's osteoporosis.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because estrogen-only therapy would increase the risk of endometrial cancer in a post-hysterectomy patient and may exacerbate osteoporosis without the balancing effect of progesterone.
**Option B:** This option is incorrect because progesterone-only therapy is not a suitable choice for menopausal women, as it may not adequately address menopausal symptoms or prevent osteoporosis.
**Option C:** This option is incorrect because tibolone is a synthetic hormone that contains estrogen, progesterone, and androgen components. While it may be beneficial for menopausal symptoms, it's not the best choice for this patient due to her osteoporosis and the need for a more tailored regimen.
**Clinical Pearl / High-Yield Fact**
When prescribing HRT in post-hysterectomy patients, always consider the need for a combination of estrogen and progesterone to prevent osteoporosis and endometrial cancer. This approach will help ensure a safe and effective treatment plan.
**Correct Answer:** C.